NCT02171520View on ClinicalTrials.gov

Bioequivalence of Two Different Generations of Drug Product of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

August 31, 2008

Conditions
Healthy
Interventions
DRUG

Dabigatran etexilate generation I

DRUG

Dabigatran etexilate generation II

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02171520 - Bioequivalence of Two Different Generations of Drug Product of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter